本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.6075
+0.00230.38%
成交量:3,951
成交額:2,395.33
市值:369.42萬
市盈率:-4.47
高:0.6136
開:0.6136
低:0.6000
收:0.6052
52周最高:2.79
52周最低:0.5700
股本:608.09萬
流通股本:501.95萬
量比:0.20
換手率:0.08%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
淨資產收益率:-1708.61%
總資產收益率:-22.79%
市淨率:0.87
市盈率(LYR):-4.47

資料載入中...

2026/04/27

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/26

SEC問詢函

Form CORRESP - Correspondence
2026/01/22

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/01/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/06/30

SEC問詢函

Form CORRESP - Correspondence
2025/06/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/04/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/06/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/08

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/26

SEC問詢函

Form CORRESP - Correspondence
2023/08/10

SEC問詢函

Form CORRESP - Correspondence